3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
11
Precancerous Conditions
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Male Urogenital Diseases
2
Colonic Neoplasms
2
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Non-melanoma Skin Cancer
1
Neoplasms
1
Lung Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Cancer Risk
1
Arsenic Poisoning
1
Adenomatous Polyps
1
Interventions
Colonoscopy
3
Cholecalciferol
2
Aspirin
2
alpha-Tocopherol
1
Vitamin E
1
Ursodeoxycholic Acid
1
Selenium
1
Restraint, Physical
1
Polymerase Chain Reaction
1
Narrow Band Imaging
1
Metformin
1
Mass Spectrometry
1
Gene Expression Profiling
1
Folic Acid
1
Erlotinib Hydrochloride
1
Endoscopy
1
Eicosapentaenoic Acid
1
Eflornithine
1
Contraceptive Devices, Female
1
Clinical Chemistry Tests
1
Chromatography, Liquid
1
Chromatography, Gas
1
Celecoxib
1
Calcium Carbonate
1
Calcium
1
Amplified Fragment Length Polymorphism Analysis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Adenomatous Polyps
×
Selenium
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts